Xenon Pharmaceuticals Inc. logo XENE - Xenon Pharmaceuticals Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 22
HOLD 0
SELL 0
STRONG
SELL 0
| PRICE TARGET: $85.00 DETAILS
HIGH: $100.00
LOW: $60.00
MEDIAN: $89.50
CONSENSUS: $85.00
UPSIDE: 56.91%

Profitability Ratios

Ratio Value
GP Margin 66.1%
EBIT Margin -4598.6%
EBITDA Margin -4564.7%
Operating Margin -4974.3%
Pretax Margin -4598.6%
Cont. Ops Margin -4612.1%
Net Margin -4612.1%
Bottom Line Margin -4612.1%

Liquidity Ratios

Ratio Value
Current Ratio 13.42
Quick Ratio 13.42
Solvency Ratio -0.859
Cash Ratio 4.77

Valuation Ratios

Ratio Value
Price/Earnings
-10.27
Hist. avg: 14.5
Peers avg: 17.0
PEG Ratio -0.23
Forward PEG -0.23
Price/Book 6.11
Price/Sales 473.62
Price/FCF -12.69
Price/Op Cash Flow -12.73

Debt Ratios

Ratio Value
Debt/Assets 0.0081
Debt/Equity 0.0137
Debt/Capital 0.0135
Long-Term Debt/Capital 0.0000
Financial Leverage 1.69

Cash Flow Ratios

Ratio Value
Working Capital Turnover 0.01
Operating Cash Flow Ratio -6.679
Operating Cash Flow/Sales -3721.6%
Free Cash Flow/Operating Cash Flow 100.3%

Coverage Ratios

Ratio Value
Debt Service Coverage -224.13
Interest Coverage 0.0000
Short-Term Operating Cash Flow Coverage -182.19
Operating Cash Flow Coverage -35.14
Capital Expenditure Coverage -349.33
Dividend + Capital Expenditure Coverage -349.33

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 0.09
EPS -4.365
Debt/Share 0.1002
Cash/Share 6.93
Book Value/Share 7.34
Tangible BV/Share 7.34
Equity/Share 7.34
Operating Cash Flow/Share -3.522
Capital Expenditure/Share 0.010
FCF/Share -3.532

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 1.003
Earnings Before Tax/EBIT 0.924
Price/Fair Value 6.11
Debt/Market Cap 0.0004
Effective Tax Rate -0.3%
Enterprise Value Multiple -9.82